Ishita Drugs & Industries Faces Mixed Performance Amid Technical Evaluation Adjustments
Ishita Drugs & Industries has experienced a recent evaluation adjustment, reflecting mixed performance metrics. While the company reported growth in net sales and a profit after tax, long-term fundamentals indicate challenges, including a modest return on equity and a weak EBIT to interest ratio, highlighting its complex market position.
Ishita Drugs & Industries has recently undergone an adjustment in evaluation, reflecting changes in its underlying technical trends. The stock's technical indicators have shifted, with the MACD showing a mildly bullish stance on a weekly basis, while the monthly perspective leans towards a mildly bearish outlook. The Bollinger Bands indicate a bearish trend for both weekly and monthly periods, and moving averages on a daily basis also suggest a bearish sentiment.In terms of performance metrics, Ishita Drugs has reported a mixed return profile. Over the past year, the stock has generated a return of -6.25%, contrasting with a 3-year return of 31.55%. The company's net sales for the latest six months have shown growth, reaching Rs 9.96 crore, while the profit after tax for the quarter peaked at Rs 0.30 crore. Despite these positive indicators, the long-term fundamentals reveal challenges, including a modest average return on equity of 8.40% and a weak EBIT to interest ratio of 0.85.
Overall, the recent revision in Ishita Drugs & Industries' evaluation underscores the complexities of its market position and performance indicators.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
